Literature DB >> 31386198

Benign hilar bile duct strictures resected as perihilar cholangiocarcinoma.

S Otsuka1,2, T Ebata1, Y Yokoyama1, T Igami1, T Mizuno1, J Yamaguchi1, S Onoe1, N Watanabe1, Y Shimoyama2, M Nagino1.   

Abstract

BACKGROUND: Differentiation between perihilar cholangiocarcinoma (PHCC) and benign strictures is frequently difficult. The aim of this study was to investigate the incidence and long-term outcome of patients with tumours resected because of suspicion of PHCC, which ultimately turned out to be benign (malignancy masquerade).
METHODS: Patients who underwent surgical resection with a diagnosis of PHCC between 2001 and 2016 were reviewed retrospectively.
RESULTS: Among 707 consecutive patients, 685 had PHCC and the remaining 22 (3·1 per cent) had benign biliary stricture. All patients with benign disease underwent major hepatectomy, with no deaths. Preoperative histological assessment using bile duct biopsy or aspiration cytology had a high specificity (90 per cent), low sensitivity (62 per cent) and unsatisfactory accuracy (63 per cent). Despite the increasing use of histological assessment, the incidence of benign strictures resected did not decrease over time, being 0·9 per cent in 2001-2004, 4·0 per cent in 2005-2008, 3·8 per cent in 2009-2012 and 2·9 per cent in 2013-2016. The final pathology of benign strictures included IgG4-related sclerosing cholangitis (9 patients), hepatolithiasis (4), granulomatous cholangitis (3), non-specific chronic cholangitis (3), benign strictures after cholecystectomy (2), and a benign stricture possibly caused by parasitic infection (1). The 10-year overall survival rate for the 22 patients with benign stricture was 87 per cent, without recurrence of biliary stricture.
CONCLUSION: The incidence of benign strictures resected as PHCC as a proportion of all resections was relatively low, at 3·1 per cent. Currently, unnecessary surgery for suspected PHCC is unavoidable.
© 2019 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Year:  2019        PMID: 31386198     DOI: 10.1002/bjs.11257

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

Review 1.  Adenomyomatous hyperplasia of the extrahepatic bile duct: a systematic review of a rare lesion mimicking bile duct carcinoma.

Authors:  Keishi Sugimachi; Yohei Mano; Yoshihiro Matsumoto; Tomohiro Iguchi; Kenichi Taguchi; Terumasa Hisano; Rie Sugimoto; Masaru Morita; Yasushi Toh
Journal:  Clin J Gastroenterol       Date:  2021-01-05

Review 2.  Preoperative Management of Perihilar Cholangiocarcinoma.

Authors:  Ryan J Ellis; Kevin C Soares; William R Jarnagin
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

Review 3.  Liquid biopsy in cholangiocarcinoma: Current status and future perspectives.

Authors:  Gianluca Rompianesi; Marcello Di Martino; Alex Gordon-Weeks; Roberto Montalti; Roberto Troisi
Journal:  World J Gastrointest Oncol       Date:  2021-05-15

Review 4.  Fifty-year history of biliary surgery.

Authors:  Masato Nagino
Journal:  Ann Gastroenterol Surg       Date:  2019-09-30

5.  Non-invasive detection of biliary tract cancer by low-coverage whole genome sequencing from plasma cell-free DNA: A prospective cohort study.

Authors:  Xiang Wang; Xiao-Hui Fu; Zi-Liang Qian; Teng Zhao; An-Qi Duan; Xiang Ruan; Bin Zhu; Lei Yin; Yong-Jie Zhang; Wen-Long Yu
Journal:  Transl Oncol       Date:  2020-10-12       Impact factor: 4.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.